Status:
TERMINATED
Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Age-Related Macular Degeneration
Alzheiner's Disease
Eligibility:
All Genders
45+ years
Brief Summary
Background: \- Alzheimer s disease affects the brain and causes memory and thinking problems in older people. Macular degeneration (MD) is an eye condition. It is the leading reason that people over ...
Detailed Description
Objective: Age-related macular degeneration (AMD) and Alzheimer s disease (AD) are both neurodegenerative diseases which affect a similar demographic of patients. Beyond age being a common risk facto...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patient must be enrolled in the 09-M-0198 protocol.
- In those participants that require special assistance, we will request that they be accompanied by a care taker to provide proper care and monitoring.
- EXCLUSION CRITERIA:
- Patients:
- The diagnosis of a different type of dementia, including frontotemporal dementia, normal pressure hydrocephalus, Lewy body dementia, Parkinson s disease dementia, Huntington s disease, or vascular dementia.
- Any medical contraindication to the procedures performed in the study, or any current severe medical or psychiatric illness other than Alzheimer s disease.
- Behavioral symptoms that would preclude the gathering of data for the study, or advanced disease such that participants cannot provide assent.
- Controls:
- The diagnosis of a brain disorder.
- Any medical contraindication to the procedures performed in the study, or any current severe medical or psychiatric illness.
Exclusion
Key Trial Info
Start Date :
August 13 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2017
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT02226835
Start Date
August 13 2014
End Date
January 24 2017
Last Update
September 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892